The Concept of Continuous Dopaminergic Stimulation: What We Should Consider when Starting Parkinson’s Disease Treatment

Publisher： Karger

E-ISSN： 1660-2862|7|1-3|213-215

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.7, Iss.1-3, 2010-03, pp. : 213-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem cell therapy for Parkinson’s disease: where do we stand?

By Roybon Laurent   Christophersen Nicolaj   Brundin Patrik   Li Jia-Yi  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 261-273

Springer Publishing Company

Access to resources Recommend Favorite

Oxidative Stress and Aminopeptidases in Parkinson’s Disease Patients with and without Treatment

By  

Neurodegenerative Diseases, Vol. 8, Iss. 3, 2010-08 ,pp. : 109-116

Karger

Access to resources Recommend Favorite

Stem-Cell-Based Strategies for the Treatment of Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 4, Iss. 4, 2007-07 ,pp. : 339-347

Karger

Access to resources Recommend Favorite

Parkinson’s disease: clinical aspects

By Klockgether Thomas  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 115-120

Springer Publishing Company

Access to resources Recommend Favorite

Neuronal pathology in Parkinson’s disease

By Schulz Jörg   Falkenburger Björn  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 135-147

Springer Publishing Company

Access to resources Recommend Favorite